Related Experiment Video
Updated: Aug 31, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans
1Department of Medicine, University of Washington School of Medicine, Seattle, USA. surawicz@u.washington.edu
Abstract:
Probiotics are living organisms which, when ingested, have a beneficial therapeutic effect. Examples are bacteria, especially Lactobacillus rhamnosus GG, and the yeast Saccharomyces boulardii. Controlled trials indicate a benefit of both of these in the prevention of antibiotic-associated diarrhoea. Other less effective probiotics are Lactinex, Enterococcus faecium and bifidobacteria. In the difficult clinical problem of recurrent Clostridium difficile disease, S. boulardii as an adjunct to antibiotics has shown benefit in controlled trials. There is, however, less convincing evidence for the efficacy of Lactobacillus GG in this disease. Additional controlled trials and safety studies are needed before there can be a widespread endorsement of probiotics for these two conditions.
Related Concept Videos
Probiotics
Microbiota Modulation by Antibiotics
Dysbiosis of the Gut Microbiota
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Development of Human Microbiota
Introduction to the Human Microbiota

